Intervju med Kjell G. Stenberg VD på Cyxone
I samband med Cyxones emission så har Analyst Group intervjuat VD Kjell G. Stenberg.
Comment
2024-06-26
Comment on ODI Pharma’s Strategic Market Entry to Switzerland
Equity research report
2024-06-05
ODI Pharma Q1-24
2024-05-08
STENOCARE Q1-24
2024-05-06
ODI Pharma
Video
Interview with ODI Pharma’s Chairman of the Board Volker Wiederrich